Gestodene
As of the edition of 20 October 2026, Gestodene is a small molecule: marketed, first approved in 1988 (FR); acts on PGR.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2005
- Kind
- Small molecule
- Brand name
- Minulet
- First approved
- 27 January 1988 (FR)
- Approvals on record
- 3 in 3 regions
- Holder of the most recent approval
- Berlis AG; 3 holders in all
- Registered trials
- 7, 1 stopped early
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| PGR | Progesterone receptor | P06401 |
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 2 | 4 | 3 | 0 | 1 |
| Phase 3 | 2 | 2 | 0 | 0 |
| Phase 4 | 1 | 1 | 0 | 0 |
| All trials | 7 |